Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Scott Lee Dryden-Peterson, M.D.

Concepts (244)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Botswana39202410492.450 Why?
Antiretroviral Therapy, Highly Active10202018941.530 Why?
HIV Infections342024173371.470 Why?
Infectious Disease Transmission, Vertical6201613510.800 Why?
Anti-HIV Agents13202445240.730 Why?
Pregnancy Complications, Infectious7201521490.710 Why?
Neoplasms132023221310.660 Why?
Zidovudine220116240.660 Why?
Lymphoma, AIDS-Related12018790.600 Why?
Uterine Cervical Neoplasms7202120200.580 Why?
Hodgkin Disease2202213780.560 Why?
CD4 Lymphocyte Count5202225670.510 Why?
Lymphoma, Non-Hodgkin2202113720.480 Why?
Healthcare Disparities2202133510.460 Why?
Anemia2201315040.420 Why?
Anti-Retroviral Agents3201917820.410 Why?
Health Services Accessibility4202154300.400 Why?
Circumcision, Male320201480.390 Why?
Social Class1202119920.390 Why?
Brachytherapy2201612230.390 Why?
Cancer Care Facilities120144210.370 Why?
Cisplatin1201616500.350 Why?
Mammography1202124300.340 Why?
Developing Countries6202028670.340 Why?
Medical Oncology3201923170.320 Why?
Benzoxazines220243160.320 Why?
Epidemics120145120.310 Why?
Neutropenia120138850.300 Why?
Breast Neoplasms42024209880.300 Why?
Reverse Transcriptase Inhibitors120116210.290 Why?
Viral Load6202033250.290 Why?
Prenatal Diagnosis1201512650.290 Why?
Anti-Infective Agents120139830.260 Why?
Adult3720242209690.260 Why?
Stillbirth420203680.260 Why?
Alkynes220243200.250 Why?
Pandemics3202286450.240 Why?
Cyclopropanes220244320.240 Why?
Capacity Building220192590.230 Why?
Quality of Health Care1201843210.210 Why?
Quality of Life12024133470.210 Why?
Humans6020247606170.200 Why?
Female4420243921480.200 Why?
HIV-16202068580.190 Why?
Antiviral Agents3202330390.190 Why?
Middle Aged2720242205840.190 Why?
Ritonavir120223290.180 Why?
Patient Acceptance of Health Care3202131940.170 Why?
Pregnancy Outcome2202029210.160 Why?
Quarantine120201820.150 Why?
Delivery of Health Care1201553320.150 Why?
Telemedicine1201530500.140 Why?
Pregnancy112020298680.140 Why?
Mass Screening4202154240.140 Why?
Pneumonia, Pneumocystis120182420.140 Why?
Vincristine1201810360.130 Why?
Cohort Studies62022414570.130 Why?
Serologic Tests120183810.130 Why?
Sarcoma, Kaposi120183740.130 Why?
RNA, Viral3201828380.120 Why?
Tuberculosis, Pulmonary220128310.120 Why?
Acquired Immunodeficiency Syndrome2201421970.120 Why?
Forefoot, Human12014310.120 Why?
Antitubercular Agents2201513740.120 Why?
Prospective Studies72022543600.120 Why?
Antineoplastic Agents42018136350.120 Why?
Condylomata Acuminata12014750.110 Why?
Phlebotomy120151370.110 Why?
Male2620223603580.110 Why?
Primary Health Care2202246680.110 Why?
Uterine Cervical Diseases12014730.110 Why?
Prednisone1201815620.110 Why?
Vaginal Neoplasms120141040.110 Why?
Travel120197960.110 Why?
Causality1201912400.110 Why?
Interinstitutional Relations120142360.110 Why?
Neoplasm Staging22019111160.100 Why?
Uterine Hemorrhage120142400.100 Why?
Cyclophosphamide1201822180.100 Why?
Referral and Consultation2202235990.100 Why?
World Health Organization1201813210.100 Why?
Medicine, African Traditional12012310.100 Why?
Infant Mortality220137510.100 Why?
Doxorubicin1201822240.100 Why?
Antibodies, Neutralizing1202119360.100 Why?
Lymphoma, Large B-Cell, Diffuse1202114050.090 Why?
Massachusetts2202188330.090 Why?
Incidence52019213370.090 Why?
Communicable Disease Control220208460.090 Why?
Adolescent122022882340.090 Why?
Antibodies, Viral1202131500.090 Why?
Inflammatory Breast Neoplasms120121470.090 Why?
Advisory Committees120147870.090 Why?
Sputum120125060.080 Why?
Aerosols120126350.080 Why?
Proportional Hazards Models42019124470.080 Why?
Infant, Newborn72019261800.080 Why?
Kaplan-Meier Estimate2201864740.080 Why?
Waldenstrom Macroglobulinemia1201810730.080 Why?
Vaccination1202133700.080 Why?
Patient-Centered Care1201914180.080 Why?
Drug Utilization1201511860.080 Why?
Ambulatory Care Facilities120159340.080 Why?
Perinatal Care120112440.080 Why?
Young Adult132022591790.080 Why?
Prenatal Exposure Delayed Effects2201125180.080 Why?
Cough120125950.080 Why?
Health Services Research2201918080.080 Why?
Pyrazoles1201820080.080 Why?
HIV Seropositivity120139590.080 Why?
Particle Size1201216480.070 Why?
Exanthema120125030.070 Why?
Health Resources120139330.070 Why?
Sensitivity and Specificity12022146480.070 Why?
Intensive Care Units, Neonatal120138460.070 Why?
Time Factors32019399130.070 Why?
Treatment Outcome52018645680.070 Why?
Pyrimidines1201830270.070 Why?
Disease-Free Survival1201668070.070 Why?
Early Detection of Cancer1202031960.070 Why?
Retrospective Studies62021805660.070 Why?
Premature Birth2202017820.060 Why?
Sex Factors12019105480.060 Why?
Health Personnel1201933330.060 Why?
Aged820241690420.060 Why?
Risk Factors82019741150.060 Why?
Prevalence52021156890.060 Why?
Uganda3201513320.060 Why?
Infant42013361520.060 Why?
Logistic Models22016132450.050 Why?
Rural Population3201922760.050 Why?
Tuberculosis, Multidrug-Resistant120119340.050 Why?
Breast Feeding1201113540.050 Why?
Papillomavirus Infections1201416110.050 Why?
Tuberculosis1201520150.050 Why?
National Cancer Institute (U.S.)120232960.050 Why?
Comorbidity12016105050.050 Why?
Retreatment220155960.050 Why?
Boston1201493130.050 Why?
Mycobacterium tuberculosis1201219140.050 Why?
Streptococcus agalactiae120023370.050 Why?
Confidence Intervals2201829250.040 Why?
Hospital Mortality1201352930.040 Why?
Skin Neoplasms1201858120.040 Why?
Child Development1201123000.040 Why?
Africa South of the Sahara120217450.040 Why?
Multilevel Analysis120191450.040 Why?
Carcinoma, Squamous Cell1201440200.040 Why?
Pneumocystis carinii12018720.040 Why?
Cluster Analysis2201827000.040 Why?
Infant, Small for Gestational Age120204620.040 Why?
United States32023722720.040 Why?
Parents1201235630.040 Why?
HIV Antigens120183250.040 Why?
Selection Bias120193590.040 Why?
Antineoplastic Combined Chemotherapy Protocols12018117360.040 Why?
Genome, Bacterial120027830.040 Why?
Feasibility Studies2202252390.040 Why?
HIV Seronegativity120182110.030 Why?
Africa120197100.030 Why?
Treatment Failure2201526350.030 Why?
Age Factors32021183810.030 Why?
Cross-Sectional Studies42020260490.030 Why?
HIV1202315790.030 Why?
Minority Groups1202312020.030 Why?
Streptomycin12015690.030 Why?
United Nations120161490.030 Why?
Ethambutol12015590.030 Why?
Drug Combinations1202120480.030 Why?
Pyrazinamide12015600.030 Why?
Ovarian Neoplasms1201248490.030 Why?
Evidence-Based Practice120194940.030 Why?
Delayed Diagnosis120184630.030 Why?
Income1202318700.030 Why?
Biopsy2201867620.030 Why?
Coitus120141320.030 Why?
Awareness120186490.030 Why?
Isoniazid120152830.030 Why?
Health Care Surveys1202024230.030 Why?
Rifampin120153390.030 Why?
Severity of Illness Index12011158280.030 Why?
Aged, 80 and over42022588940.030 Why?
Sexual Partners120188000.030 Why?
Adenine120189850.030 Why?
Program Development1201912930.030 Why?
Survival Rate22018127190.030 Why?
Data Collection1202133150.020 Why?
Skin2201844730.020 Why?
Multivariate Analysis22018120430.020 Why?
HIV Antibodies1201813020.020 Why?
Cost of Illness1202119350.020 Why?
Survival Analysis12024100730.020 Why?
Paired Box Transcription Factors120122060.020 Why?
Organizational Objectives120134260.020 Why?
Vaginal Smears120144990.020 Why?
Continuity of Patient Care1201810660.020 Why?
Bacteriological Techniques120122750.020 Why?
Radiotherapy Dosage1201828970.020 Why?
Family Characteristics120169920.020 Why?
Community Health Services120166540.020 Why?
Histocytochemistry120126960.020 Why?
Goals120167080.020 Why?
Cervix Uteri120145700.020 Why?
Rural Health120122960.020 Why?
Piperidines1201816550.020 Why?
Forecasting1201829240.020 Why?
Patient Selection1202142370.020 Why?
Self Report1202037230.020 Why?
Population Surveillance1201925950.020 Why?
Vagina120148410.020 Why?
Practice Guidelines as Topic2201973890.020 Why?
Body Size120114630.020 Why?
International Cooperation1201314210.020 Why?
Microscopy120129050.020 Why?
Health Policy1201926820.020 Why?
Clinical Trials as Topic1202279950.020 Why?
Anthropometry1201113380.020 Why?
Cooperative Behavior1201315040.020 Why?
Drug Therapy, Combination1201663050.020 Why?
Socioeconomic Factors1201977980.020 Why?
Delivery of Health Care, Integrated120139400.020 Why?
Birth Weight1201221010.010 Why?
Longitudinal Studies12020145910.010 Why?
Drug Resistance, Bacterial1201110480.010 Why?
Cause of Death1201336830.010 Why?
Health Knowledge, Attitudes, Practice1201840070.010 Why?
Recurrence1201584260.010 Why?
Predictive Value of Tests12018152510.010 Why?
Serotyping120023250.010 Why?
Randomized Controlled Trials as Topic12018101990.010 Why?
Streptococcus pyogenes120022920.010 Why?
Health Care Costs1201332380.010 Why?
Virulence1200212990.010 Why?
Immunohistochemistry12012110690.010 Why?
Species Specificity1200224110.010 Why?
Streptococcal Infections120026170.010 Why?
Streptococcus pneumoniae120027300.010 Why?
Biological Evolution1200210700.010 Why?
Phylogeny1200228060.010 Why?
Reproducibility of Results12012200740.010 Why?
Oligonucleotide Array Sequence Analysis1200237770.010 Why?
Follow-Up Studies12015390630.010 Why?
Amino Acid Sequence12002134410.010 Why?
Molecular Sequence Data12002176290.010 Why?
Dryden-Peterson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (244)
Explore
_
Co-Authors (67)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.